Riccardo Alessandro Selected Research

Interleukin-17 (Interleukin 17)

1/2023	Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome.
1/2019	ILC3 in Axial Spondyloarthritis: the Gut Angle.
1/2018	Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome.
11/2017	IL-17 polarization of MAIT cells is derived from the activation of two different pathways.
9/2015	Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis.
9/2015	Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis.
6/2012	Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Riccardo Alessandro Research Topics

Disease

34	Neoplasms (Cancer) 05/2023 - 03/2005
14	Inflammation (Inflammations) 12/2023 - 12/2010
10	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2018 - 11/2007
9	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 04/2004
9	Hypoxia (Hypoxemia) 05/2022 - 05/2014
9	Ankylosing Spondylitis 01/2021 - 12/2010
8	Colonic Neoplasms (Colon Cancer) 03/2023 - 07/2006
7	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2007
7	Fabry Disease (Fabry's Disease) 01/2021 - 06/2012
5	Leukemia 01/2023 - 11/2007
5	Giant Cell Arteritis (Horton Disease) 08/2022 - 02/2013
5	Crohn Disease (Crohn's Disease) 01/2021 - 12/2010
3	Carcinogenesis 03/2023 - 11/2005
3	Melanoma (Melanoma, Malignant) 01/2023 - 12/2017
3	Osteosarcoma (Osteogenic Sarcoma) 10/2020 - 11/2017
3	Multiple Myeloma 02/2020 - 01/2019
3	Rheumatoid Arthritis 10/2018 - 01/2014
3	Lung Neoplasms (Lung Cancer) 01/2017 - 12/2014
2	Necrosis 01/2023 - 07/2014
2	Lymphoma (Lymphomas) 01/2023 - 01/2018
2	Dysbiosis 01/2021 - 06/2017
2	Ileitis 01/2021 - 06/2017
2	Pain (Aches) 11/2020 - 01/2019
2	Fatigue 11/2020 - 01/2019
2	Fibromyalgia (Fibrositis) 11/2020 - 01/2019
2	Bone Diseases (Bone Disease) 02/2020 - 11/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 04/2012
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 07/2018 - 06/2014
2	Genetic Translocation (Chromosomal Translocation) 07/2018 - 02/2015
2	Disease Progression 11/2017 - 07/2014
2	Sjogren's Syndrome (Sjogren Syndrome) 11/2017 - 02/2012
1	Colitis 04/2024
1	Wounds and Injuries (Trauma) 12/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Bone Resorption 11/2021
1	Osteoporosis 11/2021
1	Squamous Cell Carcinoma of Head and Neck 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2021
1	Dyslipidemias (Dyslipidemia) 04/2021
1	Osteoarthritis 02/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2005
14	MicroRNAs (MicroRNA)IBA 03/2022 - 07/2014
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2005
8	CytokinesIBA 03/2023 - 12/2010
7	Interleukin-17 (Interleukin 17)IBA 01/2023 - 06/2012
6	Interleukin-22 (IL-22)IBA 08/2022 - 02/2012
6	Messenger RNA (mRNA)IBA 01/2022 - 04/2004
5	InterleukinsIBA 01/2023 - 02/2013
5	Long Noncoding RNAIBA 01/2023 - 08/2015
5	GalactosidasesIBA 11/2018 - 06/2012
4	Interleukin-23 (Interleukin 23)IBA 01/2019 - 06/2012
4	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 04/2008
3	LigandsIBA 10/2022 - 01/2019
3	Oxygen (Dioxygen)IBA 05/2022 - 05/2020
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021 - 12/2010
3	Transcription Factors (Transcription Factor)IBA 05/2020 - 05/2014
3	EnzymesIBA 11/2018 - 06/2012
3	CurcuminIBA 07/2018 - 09/2015
3	Interleukin-9 (Interleukin 9)IBA 01/2016 - 09/2015
3	Oncogene Proteins (Oncogene Protein)IBA 02/2015 - 01/2011
2	AntioxidantsIBA 04/2024 - 07/2018
2	Small Interfering RNA (siRNA)IBA 12/2023 - 01/2017
2	LipopolysaccharidesIBA 12/2023 - 03/2023
2	Volatile Oils (Essential Oils)IBA 12/2023 - 03/2023
2	citral (neral)IBA 12/2023 - 09/2020
2	FlavonoidsIBA 05/2023 - 03/2023
2	xanthohumolIBA 03/2023 - 08/2021
2	nobiletinIBA 03/2023 - 08/2021
2	Interleukin-6 (Interleukin 6)IBA 03/2023 - 01/2014
2	Fluorouracil (Carac)FDA LinkGeneric 05/2022 - 04/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2017
2	CateninsIBA 05/2020 - 12/2017
2	AmphiregulinIBA 01/2019 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 07/2006
2	ChemokinesIBA 01/2017 - 10/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2015 - 06/2014
2	HydrolasesIBA 01/2015 - 06/2012
2	Interleukin-10 (Interleukin 10)IBA 11/2012 - 12/2010
2	ProteomeIBA 11/2007 - 11/2005
1	2,4-dinitrofluorobenzene sulfonic acidIBA 04/2024
1	AcidsIBA 04/2024
1	PolyphenolsIBA 03/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	givinostat hydrochlorideIBA 01/2023
1	Sodium Glutamate (Accent)IBA 01/2023
1	InterferonsIBA 01/2023
1	givinostatIBA 01/2023
1	Immunoglobulin Fab FragmentsIBA 10/2022
1	TetraspaninsIBA 10/2022
1	Terpenes (Terpenoids)IBA 11/2021
1	oxidized low density lipoproteinIBA 04/2021
1	LDL CholesterolIBA 04/2021
1	Connexin 43 (Connexin43)IBA 02/2021
1	ConnexinsIBA 02/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021

Therapy/Procedure

9	Therapeutics 08/2021 - 03/2013
2	Drug Therapy (Chemotherapy) 08/2021 - 11/2017
2	Hyperbaric Oxygenation 11/2020 - 01/2019